Lowering of serum lipid levels by "masked" nicotinic acid derivatives.
D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005750:Gastric Juice / Q000378:metabolism; D006168:Guinea Pigs; D006834:Hydrazines / Q000138:chemical synthesis / Q000494:pharmacology; D006877:Hydroxamic Acids / Q000138:chemical synthesis / Q000494:pharmacology; D000960:Hypolipidemic Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000032:analysis / Q000187:drug effects; D008297:Male; D009539:Nicotinic Acids / Q000138:chemical synthesis / Q000494:pharmacology*; D011725:Pyridines / Q000138:chemical synthesis / Q000494:pharmacology; D051381:Rats; D012867:Skin / Q000187:drug effects; D013329:Structure-Activity Relationship; D014280:Triglycerides / Q000032:analysis / Q000097:blood
D005230:Fatty Acids, Nonesterified; D006834:Hydrazines; D006877:Hydroxamic Acids; D000960:Hypolipidemic Agents; D008055:Lipids; D009539:Nicotinic Acids; D011725:Pyridines; D014280:Triglycerides; D002784:Cholesterol